Kailera Therapeutics (KLRA) vs uniQure N.V. (QURE)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
uniQure N.V. is the larger company by market cap ($1.57 billion vs $1.51 billion), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | KLRA | QURE |
|---|---|---|
| Share price | $11.61 | $22.59 |
| Market cap | $1.51B | $1.57B |
| 1-day change | +16.10% | +0.22% |
| YTD return | — | -5.60% |
| 1-year return | — | -64.51% |
| 5-year return | — | -24.85% |
| EPS (TTM) | $-4.51 | $-4.03 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $16.10M |
| Revenue growth (YoY) | — | -40.64% |
| Net income (latest FY) | — | $-198.97M |
| Gross margin | — | 89.53% |
| Operating margin | — | -1151.38% |
| Net margin | — | -1236.00% |
| 52-week high | $28.23 | $71.50 |
| 52-week low | $9.76 | $8.73 |
| Distance from 52-week high | -58.87% | -68.41% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +265.20% | +175.92% |
| Average volume | 865.82K | 1.97M |
| Shares outstanding | 129.64M | 69.37M |
| Employees | 145 | 221 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Kailera Therapeutics
KLRA stock →Kailera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company developing therapies for obesity and related conditions.
Health Care · Biotechnology: Pharmaceutical Preparations · 145 employees
About uniQure N.V.
QURE stock →uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States.
Health Care · Biotechnology: Pharmaceutical Preparations · 221 employees
KLRA vs QURE FAQ
Which is bigger, Kailera Therapeutics or uniQure N.V.?
uniQure N.V. (QURE) is larger, with a market capitalization of $1.57B compared with $1.51B for Kailera Therapeutics (KLRA).
Are Kailera Therapeutics and uniQure N.V. in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.